Journalism begins where hype ends

,,

The American people do not want to be tracked and recorded by AI"

—Senator Bernie Sanders

DeepMind and Isomorphic Labs Pitch “Bioresilience” Plan to Keep AI Out of Bioweapon Hands

DeepMind's AlphaFold protein-structure prediction anchors the "response" pillar of the bioresilience plan, which the companies say can speed up vaccine and treatment development.

Google DeepMind and Isomorphic Labs have set out a joint “bioresilience” approach aimed at stopping threat actors from misusing their AI models to develop biological weapons.

AI Meets Big Pharma: Isomorphic Labs Raises $2.1 Billion for AI Drug Discovery

Isomorphic Labs, founded in 2021 by DeepMind chief Demis Hassabis, has raised $2.1 billion in Series B funding to scale its AI-driven drug discovery platform.

Demis Hassabis’s AI drug discovery startup Isomorphic Labs has raised $2.1 billion in a Thrive Capital-led Series B, joined by Alphabet, GV, MGX, Temasek, CapitalG and the UK Sovereign AI Fund.